N

Nutriband
D

NTRB

4.72000
USD
-0.05
(-1.05%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-6
حجم السوق
52,373,993
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AMRS
    -0.006500
    (-10.55%)
    0.055100 USD
    B
    BYND
    -0.13500
    (-2.55%)
    5.16000 USD
    E
    ENPH
    -4.050
    (-6.37%)
    59.510 USD
    F
    FCEL
    -0.86000
    (-12.29%)
    6.14000 USD
    G
    GEVO
    -0.05500
    (-3.70%)
    1.43000 USD
    P
    PLUG
    -0.10500
    (-5.33%)
    1.86500 USD
    S
    SPWR
    0
    (0%)
    0.000000 USD
    TSLA
    TSLA
    9.69
    (3.11%)
    331.44 USD
    V
    VLGEA
    -0.435
    (-1.32%)
    32.615 USD
    المزيد
الأخبار

العنوان: Nutriband

القطاع: Healthcare
الصناعة: Biotechnology
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.